Anti-Counterfeiting Technologies


Assuming that the general concept of parallel importation, both legal and illegal, is common knowledge, one would like to discuss the growth of technologies which seek to provide fool-proof mechanisms against counterfeit products. The need for such technologies is driven by the fact that the counterfeit market is valued at $500 billion and costs the government exchequer a sizable amount. It is estimated that 7% of the world trade is in counterfeit goods. Music, software and luxury goods suffer heavily,…


Read More »

SpicyIP Tidbits: IPR Index


According to an article in the Intellectual Assets Magazine (IAM), Property Rights Alliance (PRA) released its International Property Rights Index (IPRI) Report for the year 2008, with rankings on protection for physical and intellectual property in 115 countries. In IP protection, among emerging economies, India ranks 47th along with Mauritania, with Brazil, China and Russia on 49th, 70th and 82nd positions respectively. Finland topped the rankings with Germany, UK and Japan occupying the next three slots; the US is ranked…


Read More »

SpicyIP Tidbits: Lipitor Case


Last week, we had reported that Ranbaxy was prohibited by the Court of Appeal in Netherlands from launching a generic version of Pfizer’s basic Lipitor patent on atorvastatin (EP 247633). In an interesting reversal of fortunes, the same court has invalidated Pfizer’s patent on the enantiomer of atorvastatin (EP 409281) which was challenged by Ranbaxy. Pfizer may prefer an appeal against this ruling. It may be recalled that the Nexium case too deals with patent on S-enantiomer of Omeprazole, namely…


Read More »

SpicyIP Tidbits: Interpol to Step in to Protect IPR


Tightening the noose on counterfeiting of goods for protection of IPR, a Database on International Intellectual property (DIIP) was launched at a Confederation of Indian Industry (CII) forum in Mumbai, as part of a joint initiative by the Interpol and the US Chamber of Commerce. Laying emphasis on the importance of protection of IPR in countries like India and China, Ron Noble, secretary general of Interpol and David Chavern, executive vice president and chief operating officer of the U S…


Read More »
Patent

SpicyIP Tidbits: It’s a Case of Purple Heartburn


Here’s the story so far. AstraZeneca, the Anglo-Swedish manufacturer of prescription drugs had a basic patent on Prilosec (Omeprazole), a drug used to treat gastroesophageal reflux disease (acid reflux) and heartburn. Gastroesophageal reflux disease is the name given to erosions in the oesophagus on account of churning of pepsin in the stomach over a period of time which chips away at the delicate lining of oesophagus. This patent was supposed to expire in April 2001. However, the company came up…


Read More »

A Patently Preposterous Patent?


“…be careful what you say in your blogs—blogs can work for you by denying property rights to others, they can work against you by exposing your ideas prematurely or narrowing your time window to apply for a patent, and they can establish a trail of evidence that a litigant can use against you to show a judge that your invention is an obvious extension of prior art.” So goes the blog entry which has now set the stage for the…


Read More »

SpicyIP Tidbit: Is the Sheen Wearing off?


If reports from the industry are any indication, the signs are that the appreciation of the Rupee combined with an acute shortage of trained professionals for basic research are taking its toll on India’s image as a Research and Development outsourcing hub. According to Mr.Pari Natarajan, Chief Executive of Zinnov, an R&D consultancy firm: “Some companies witnessed a 20 percent rise last year in the cost of running their R&D operations in India. If this trend continues, the cost advantage…


Read More »

SpicyIP Tidbit: Search for Traditional Remedies for Bird Flu


In a major institutional boost towards applying traditional Indian medicine to modern day afflictions, the National Institute of Siddha (NIS), Chennai has announced that it would jointly work with six other institutions namely, University of Madras, Anna University, Dr. M.G.R.Medical University, King Institute, MadrasMedicalCollege and Tamil Nadu Veterinary and AnimalSciencesUniversity, in the fight against bird flu. In this connection, a day-long session was held at NIS on Microbiology, Virology and Clinical Parameters in Avian Flu (Siddha perspective). The details are…


Read More »

SpicyIP Tidbit: Bloopers Galore


Mysteriously, another form of Intellectual Property has cropped out of nowhere. Introducing the “Geographical Indicator Patent” also referred to as GIP. Atleast that is what The Telegraph says: “Pakistan opposes Jammu and Kashmir’s efforts to get a geographical indicator patent (GIP) on its centuries-old Sozni shawls, saying this embroidery craft is in vogue in its part of Kashmir, too. The neighbouring country’s traders want Sozni shawls made in Pakistan-occupied Kashmir included under the patent Kashmiri Sozni. Jammu and Kashmir’s Craft…


Read More »

SpicyIP Tidbit: “RIN”


Rural India, it appears, is telling its urban counterpart that it is time the latter caught up with it in terms of innovation. After NIF, we have another NGO helping rural innovators get their due. Rural Innovations Network (RIN), founded by a Mechanical engineer (cant help feeling proud of one of my brethren) Paul Basil, has lent itself to the cause of making commercially viable products out of rural innovations. The primary areas of RIN’s focus are innovations related to…


Read More »